Isansys Lifecare Ltd, the provider of complete real-time physiological patient data services and systems, has been named as the winner of the prestigious Best New Medtech Development Programme at this year’s OBN awards.
Isansys triumphed over other finalists at the award ceremony held at Oxford’s Ashmolean Museum, to be named the winner by an independent panel of judges. The award, which was sponsored and presented by Milton Park, was given in recognition of Isansys innovative technology and vital signs monitoring platform which is believed will change the way healthcare delivery is provided.
Keith Errey, CEO of Isansys Lifecare, which is based in Abingdon, Oxfordshire, said he was thrilled to have won the award and believe it reflects a highly successful year for the business.
In addition to winning this award, Isansys has won three NHS contracts and continues to grow at a rapid speed. In just six months it has nearly doubled its workforce from eight to 14 team members.
When picking up the award, Keith said: “We are absolutely delighted to have won this award in recognition of the ground-breaking and innovative projects we are working on. This is great recognition of what Isansys is doing and illustrates the benefits that our wireless real-time patient monitoring and analysis platform is now bringing to patients, clinicians and nursing staff. It also clearly highlights the hard work and dedication of our team in developing and deploying these systems.
“This award is not for Isansys but for the patients and the health care providers who are going to benefit enormously from what we are doing here.”
Rebecca Weir, cofounder and Business Development Director of Isansys, said: “We are delighted to have won this award as it reflects hugely on the vast progress Isansys has made in its technology and clinical development programmes over the past year.
“For us at Isansys, it has been really beneficial to be part of such a supportive business community enabling collaborations within both industry and healthcare. We have created something that is starting to be seen as transformational in the way we can deliver healthcare, and this award demonstrates other people's belief in what we are doing.”
Isansys was selected as finalists for three separate categories in the OBN awards: the Best New Medtech Development Programme, the Best Emerging Medtech Company, and the Best Public-Private Collaboration, Sponsored by Oxford AHSN.
The awards celebrated the key achievements within the bioscience and medical technology sector over the last year. OBN is a not-for-profit business network which provides comprehensive support for biotech and medtech companies in the Oxford and South-East biocluster and beyond.
The Patient Status Engine is a revolutionary step in the rapidly growing area of digital healthcare - a low cost platform to provide 24/7 surveillance of all patients. By automatically and continuously collecting and analysing patient data, the system can provide alerts and early warnings to clinical staff to allow them to make earlier and simpler interventions and thus prevent many avoidable and costly (both financially and personally) adverse events, regardless of whether the patients are in hospital or at home.
The winners in each of the ten categories were announced at the OBN Annual Awards Dinner which took place last night (Thursday 2 October 2014) at the Ashmolean Museum, Oxford. The event was attended by senior executives and influential players from the most innovative and dynamic biotech and medtech companies in the OBN network.
For more information and the full list of other winners of the OBN awards, please visit: http://www.obn.org.uk
NOTES TO EDITORS:
About Isansys Lifecare Ltd
Isansys Lifecare Ltd is a new generation healthcare company that provides patient surveillance and monitoring services built on an innovative, low cost and scalable digital platform.
We are working with a number of hospitals in the NHS and other leading healthcare professionals and institutes to deliver patient monitoring services and patient status solutions using the Patient Status Engine platform and new generation wireless vital signs monitors.
We operate in a wide range of healthcare settings which want to employ new patient monitoring technologies and methods to improve patient outcomes and reduce costs.
For more information about Isansys please log into www.isansys.com
Photos and interviews available on request